SpeedWeed

SEPTEMBER 17, 2021

One of the company’s owners previously worked in the pharmaceutical market and wanted to enter the cannabis industry to provide an alternative form of relief to patients, Brodsky says. Polling looks good, so I think we’re going to be all right,” he says. View original article.

Environment

Canna Law Blog

FEBRUARY 21, 2020

After reviewed scientific data of Epidiolex previously used by European and foreign health authorities, including the FDA, for the approval of the drug, the COT concluded that because the data was intended for pharmaceutical and not over-the-counter use, the “trade-off between risks and benefits that does not apply to food.”.

Food

Cannabis Law Report

JULY 26, 2021

Dr. Tyle brings over 35 years of experience in the pharmaceutical industry, with over 37 years in senior executive leadership positions encompassing research and development, clinical development, manufacturing, regulatory, business development and operations as well as roles as a board director and scientific advisory board member.

Research and Development

Cannabis Law Report

AUGUST 7, 2021

We are pioneering a new kind of pharmaceutical company that prioritizes public benefit and is committed to sustainability, accountability, and transparency. MAPS PBC strives to establish a supportive, equitable, and accessible work environment. Why work for MAPS Public Benefit Corporation (MAPS PBC)? Position Requirements.

Clinical Trials

The Joint Blog

JUNE 15, 2020

The study is titled Will medical cannabis treatment reduce pharmaceutical residues in the aquatic environment? It has different undesirable side effects, which may directly affect the environment. A new study has found that medical marijuana reduces the use of prescription drugs in nursing homes.

Therapy

Cannabis Law Report

JUNE 29, 2021

BRC works with research groups studying Cannabis and Cannabis flower to understand the plant in a scientific and federally regulated environment. Under the federal licensing regime, BRC is only allowed to source genetics and starting material from DEA-compliant or federally legal sources.

Research and Development

Veriheal

MARCH 7, 2023

Beis expressed his excitement about the factory being the largest pharmaceutical facility in Europe, where a medical cannabis industry is sprouting across Luxembourg, Germany, and Malta. “A Greece’s environment is friendly for this particular plant and we think we will have a natural advantage,” he said. billion euros ($1.67

Marijuana

Cannabis Law Report

JUNE 5, 2021

The Harare government has also approved the establishment of the Green Industry Fund, to promote local beneficiation, skills transfer and development of the local pharmaceutical industry. This is a major departure from the country’s existing foreign investment regime which requires significant local shareholding in any such venture.

Medicine

MMJ Recs

NOVEMBER 17, 2023

The community impact is visible in several key areas: Healthcare Advancements MMJ has expanded the range of treatment options available to patients, offering an alternative to conventional pharmaceuticals. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain

Cannabis Law Report

AUGUST 20, 2021

Bio Zu Farm is also managing the set-up and operation of Swiss Life Sciences Group’s state-of-the-art, controlled environment production facility in Switzerland.

Research and Development

Cannabis Law Report

DECEMBER 22, 2019

Independent farmers believe that the “marijuana Monsantos” that are muscling in are only going to make things perpetually more detrimental for the environment and the instability of the planet in the years to come. Theories abound on how to make cannabis production more sustainable. Pesticide Issues.

Packaging

Cannabis Law Report

AUGUST 19, 2019

Recently, three British MPs went to Canada on a fact-finding cross-party trip to consider the effects of a more relaxed regulatory environment in respect of cannabis. Authors – Carolyn E. Pepper and Jess Parry.

Environment

Veriheal

MARCH 18, 2021

However, the team explains that the safety and efficacy of cannabis as a chronic treatment needs to be better understood along with the interactions between cannabis and pharmaceutical medications, in the likely event that the Alzheimer’s patient is on multiple other medications. What Did The Study Find?

CBD

Cannabis Law Report

DECEMBER 4, 2019

The North American College of Pharmaceutical Technology (NACPT) is conducting a pilot series of professionals in medical cannabis workshops, and we spent a day learning and discussing food safety, regulatory tech, processes and systems. Could food safety hazards be introduced from equipment, personnel or the environment?

Safety

Cannabis Law Report

NOVEMBER 23, 2019

for the production R&D of pharmaceutical grade standardised cannabis. Here the company shares their evolution with Health Europa, exploring the production of pharmaceutical grade standardised cannabis. KANNABEIRA® is a project and a registered trademark under the company Green Donation, Ltd. KANNABEIRA and standardised cannabis.

Pharmaceutical

The Cannigma

MARCH 25, 2021

Sterling mentioned fears that officials may have about cannabis making its way out into the general population of the prison, though he added that’s a concern with any pharmaceutical provided by prison health services. Largely it’s the opaque legal and regulatory restrictions on cannabis which complicate the matter.

Marijuana

Veriheal

DECEMBER 10, 2021

These particles are normally removed when chemists create products like Delta-8 in a regulated pharmaceutical environment. When Delta-8 is produced in a regulated environment, the final product should, in theory, be completely safe for consumption. The Need for Testing and Regulation.

THC

The Cannigma

MAY 9, 2021

Indoor cultivation’s carbon footprint is so energy intensive that it is indefensible from an energy and environment perspective, argued the authors of the report. Four times the energy as the pharmaceutical industry. pharmaceutical industry energy expenditure. But there’s a price. Outdoor cultivation isn’t always much better.

Agriculture

Cannabis Law Report

OCTOBER 7, 2021

Should a future regulatory environment include personal as well as medical use? Do you see the regulation of psychedelics for uses other than pharmaceuticals developing in the same way that cannabis has over the last decade? Do you feel that Florida should be looking at these sorts of proposals too?

Legislation

Cannabis Law Report

SEPTEMBER 1, 2021

Assess regulatory environments and requirements of new jurisdictions and markets to ensure product quality is maintained throughout the entire product life cycle. Knowledge and experience working within a pharmaceutical manufacturing, packaging, and warehousing cGMP Quality Management System.

Research and Development

Cannabis Law Report

NOVEMBER 26, 2021

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. Jazz Pharmaceuticals Plc. The market is driven by rising number of countries decriminalizing and legalizing cannabis and health benefits of medical cannabis. Companies Mentioned.

Pharmaceutical

Cannabis Law Report

JULY 8, 2021

I’m thrilled to be working with the Flora team as we are aligned on creating and bringing to market sustainable products that thoughtfully consider the environment, biodiversity, and sustainable business practices.”. These and other factors may cause our actual results to differ materially from any forward-looking statement.

Supply Chain

Cannabis Law Report

SEPTEMBER 26, 2021

pharmaceutical, biotechnology, science, chemistry, microbiology or biology). Minimum 3 years relevant regulatory/compliance experience in a regulated environment, preferably in cannabis, health products, pharmaceutical, food (i.e. GMP, GPP, GDP environments). Ability to work effectively in a team-based environment.

Environment

Cannabis Law Report

JUNE 17, 2021

Patients are looking to their medical providers for information on cannabis safety, potential for interactions with pharmaceuticals, and therapeutic applications. However, the existing legal environment significantly hinders the ability of clinicians to engage with cannabis research or offer clear guidance.

Policy

Cannabis Law Report

SEPTEMBER 3, 2021

Flora Lab is acknowledged for its quality procedures which are now in line with global pharmaceutical companies after it receives GMP certification from INVIMA to manufacture cosmetics products. Has more than 18 domestic clients and sells branded products along with white-label products. Forward-looking statements are only predictions.

Supply Chain

Cannabis Law Report

FEBRUARY 18, 2022

We are one of the first to successfully complete a commercial shipment of Colombian-manufactured high-CBD pharmaceutical product to Germany available for patients in pharmacies under prescription. In addition, this reflects our increasing know-how to comply with complex and sophisticated regulatory and quality frameworks.

Extraction

Cannabis Law Report

FEBRUARY 5, 2022

5+ years’ experience in pharmaceutical industry preferably prescription medicines, narcotics, experimental drugs or products supplied via access schemes. Up to date knowledge and experience of regulated domestic and international environments for therapeutic goods. Minimum tertiary qualification in relevent field.

Medicine

Cannabis Law Report

DECEMBER 15, 2021

5+ years’ experience in pharmaceutical industry preferably prescription medicines, narcotics, experimental drugs or products supplied via access schemes. Up to date knowledge and experience of regulated domestic and international environments for therapeutic goods. Minimum tertiary qualification in relevent field.

Medicine

Cannabis Law Report

MARCH 30, 2019

The trials, to be tightly controlled in a hospital environment, are exempted from Japan’s Cannabis Control Act, which bans cannabis compounds generally. Epidiolex, manufactured by UK-based GW Pharmaceutical, was approved by the U.S. Food and Drug Administration last year.

Clinical Trials

Cannabis Law Report

JANUARY 13, 2020

The 18,700 square foot facility will deliver extractions of THC-free broad-spectrum hemp distillates and custom formulated cannabinoid blends for clients in the pharmaceutical, nutraceutical, food and cosmetic markets within a Current Good Manufacturing Practices environment.

Extraction

Cannabis Law Report

SEPTEMBER 26, 2021

JOB DESCRIPTION: Prepare, coordinate and supervise regulatory submissions for NHPs, pharmaceuticals and cosmetic products. Minimum two years of relevant experience in Regulatory Affairs and GMP in the Natural Health Products or Pharmaceutical or industry. Review product conformance and assure compliance. REQUIREMENTS: B.Sc Vision care.

Compliance

Cannabis Law Report

JUNE 9, 2021

MAPS strives to continually improve upon the supportive, equitable, and accessible work environment. MAPS is a dispersed workforce that offers full-time employment in a remote work environment. Pharmaceutical or cannabis industry experience a plus. We are committed to conscious leadership and an inclusive team dynamic.

Research and Development

LifeCannMD

AUGUST 30, 2024

Coconut Grove has embraced this change, with residents increasingly turning to medical cannabis as a natural alternative to traditional pharmaceuticals. LifeCannMD provides a welcoming and supportive environment, making patients feel comfortable discussing their health concerns.

Marijuana

Cannabis Law Report

AUGUST 18, 2022

Among the first in the nation, Phillips Lytle’s Psychedelics Practice Team combines expertise in pharmaceutical science, FDA regulations and risk management to serve the legal needs of emerging bio-tech sectors. “It also creates new opportunities for researchers, entrepreneurs, investors and pharmaceutical companies.

Therapy

Cannabis Law Report

MARCH 1, 2022

A fast-paced environment where you’ll work on a wide range of topics. 10 years of experience in the pharmaceutical industry. +5 Attracted to a life sciences biotechnology environment with potential for future continued grow. Location: San Diego or remote on the west or east coast. Position: Full-time. Opportunity.

Clinical Trials

Cannabis Law Report

JULY 8, 2021

I’m thrilled to be working with the Flora team as we are aligned on creating and bringing to market sustainable products that thoughtfully consider the environment, biodiversity, and sustainable business practices.”. These and other factors may cause our actual results to differ materially from any forward-looking statement.

Supply Chain

CannaTech

NOVEMBER 6, 2019

Acceptable practices, systems, and protocols are being rapidly mandated by larger commercial cannabinoid buyers entering from industries such as Consumer Goods, Natural Supplements, Nutraceuticals, Pharmaceuticals, Wine, Spirits and Beverage.

Cannabinoids